Highlights and Quick Summary
- Investing cash flow for the quarter ending December 31, 2022 was $11.4 Million (a -93.72% decrease compared to previous quarter)
- Year-over-year quarterly Investing cash flow decreased by -31.07%
- Annual Investing cash flow for 2022 was $226 Million (a -403.75% decrease from previous year)
- Annual Investing cash flow for 2021 was $-74.5 Million (a -368.33% decrease from previous year)
- Annual Investing cash flow for 2020 was $27.8 Million (a -68.02% decrease from previous year)
- Twelve month Investing cash flow ending December 31, 2022 was $226 Million (a -1.95% decrease compared to previous quarter)
- Twelve month trailing Investing cash flow increased by 218.31% year-over-year
Trailing Investing cash flow for the last four month:
| 31 Dec '22 | 30 Sep '22 | 30 Jun '22 | 31 Mar '22 |
|---|---|---|---|
| $226 Million | $231 Million | $71.1 Million | $71.1 Million |
Visit stockrow.com/PGEN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Investing cash flow of Precigen, Inc.
Most recent Investing cash flowof PGEN including historical data for past 10 years.Interactive Chart of Investing cash flow of Precigen, Inc.
Precigen, Inc. Investing cash flow for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | $11.42 | $181.86 | $16.57 | $16.57 | $226.42 |
| 2021 | $15.93 | $22.01 | $16.62 | $-129.1 | $-74.54 |
| 2020 | $40.18 | $0.18 | $23.97 | $-36.55 | $27.78 |
| 2019 | $54.51 | $13.78 | $-15.03 | $33.59 | $86.85 |
| 2018 | $30.74 | $-161.03 | $-13.46 | $-7.46 | $-151.21 |
| 2017 | $23.91 | $28.14 | $17.73 | $34.55 | $104.33 |
| 2016 | $16.75 | $-63.77 | $14.74 | $3.88 | $-28.39 |
| 2015 | $-1.93 | $-239.51 | $8.23 | $-26.03 | $-259.25 |
| 2014 | $10.47 | $-39.75 | $-22.6 | $25.86 | $-26.03 |
| 2013 | $-1.96 | $-126.39 | $-95.84 | $0.53 | $-223.66 |
| 2012 | $-6.53 | $-0.17 | $-16.93 | – | $-23.64 |
Business Profile of Precigen, Inc.
Sector: Healthcare
Industry: Biotechnology